AccuStem Sciences Limited
ACMSY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $73 | $60 | $28 | $45 |
| G&A Expenses | $327 | $341 | $412 | $255 |
| SG&A Expenses | $327 | $341 | $412 | $255 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $400 | $401 | $440 | $300 |
| Operating Income | -$400 | -$401 | -$440 | -$300 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$400 | -$401 | -$440 | -$300 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$400 | -$401 | -$440 | -$372 |
| % Margin | – | – | – | – |
| EPS | -0.02 | -0.02 | -0.03 | -0.03 |
| % Growth | 0% | 33.3% | 0% | – |
| EPS Diluted | -0.02 | -0.02 | -0.03 | -0.03 |
| Weighted Avg Shares Out | 16,072 | 16,072 | 12,724 | 11,435 |
| Weighted Avg Shares Out Dil | 16,072 | 16,072 | 12,724 | 11,435 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $40 |
| EBITDA | -$399 | -$401 | -$440 | -$261 |
| % Margin | – | – | – | – |